Analyst Price Targets — MRVI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 15, 2025 11:28 am | Brandon Couillard | Wells Fargo | $4.50 | $3.61 | TheFly | Maravai Lifesciences price target raised to $4.50 from $4 at Wells Fargo |
| March 21, 2025 2:28 pm | — | Stifel Nicolaus | $5.00 | $2.27 | TheFly | Maravai Lifesciences price target lowered to $5 from $10 at Stifel |
| May 9, 2024 6:15 am | Catherine Schulte | Robert W. Baird | $10.00 | $8.87 | TheFly | Maravai Lifesciences price target raised to $10 from $8 at Baird |
| December 14, 2022 8:30 am | — | Deutsche Bank | $25.00 | $15.03 | Benzinga | Deutsche Bank Initiates Coverage On Maravai LifeSciences with Buy Rating, Announces Price Target of $25 |
| December 7, 2022 4:42 am | — | RBC Capital | $22.00 | $12.50 | Benzinga | RBC Capital Initiates Coverage On Maravai LifeSciences with Outperform Rating, Announces Price Target of $22 |
Latest News for MRVI
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year ago.
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31, 2025, together with other business updates. Key Financial Results: Quarterly revenue of $49.9 million, Net loss of $(63.0) million, and Adjusted…
Maravai LifeSciences (NASDAQ: MRVI - Get Free Report) will likely be issuing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $49.0610 million for the quarter. Parties can find conference call details on the company's upcoming Q4 2025 earning
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MRVI.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.